SEC Form 4 · accession 0001127602-19-008338
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 26, 2019 · 3:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | S | 100 | $145.065 | D | 301,588 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.08 | D | 301,488 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.09 | D | 301,388 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $145.12 | D | 301,088 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.14 | D | 300,888 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.15 | D | 300,788 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.155 | D | 300,388 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.16 | D | 299,988 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.17 | D | 299,788 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.175 | D | 299,588 | D | |
| Common Stock | Feb 25, 2019 | S | 65 | $145.18 | D | 299,523 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.195 | D | 299,423 | D | |
| Common Stock | Feb 25, 2019 | S | 1,000 | $145.20 | D | 298,423 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.21 | D | 298,023 | D | |
| Common Stock | Feb 25, 2019 | S | 400 | $145.22 | D | 297,623 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.225 | D | 297,523 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.23 | D | 297,423 | D | |
| Common Stock | Feb 25, 2019 | S | 501 | $145.24 | D | 296,922 | D | |
| Common Stock | Feb 25, 2019 | S | 200 | $145.245 | D | 296,722 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.25 | D | 296,622 | D | |
| Common Stock | Feb 25, 2019 | S | 500 | $145.26 | D | 296,122 | D | |
| Common Stock | Feb 25, 2019 | S | 100 | $145.265 | D | 296,022 | D | |
| Common Stock | Feb 25, 2019 | S | 300 | $145.27 | D | 295,722 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.